Centralized Blood Processing for the Selenium and Vitamin E Cancer Prevention Trial: Effects of Delayed Processing on Carotenoids, Tocopherols, Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein 3, Steroid Hormones, and Lymphocyte Viability
- 1 March 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (3) , 727-730
- https://doi.org/10.1158/1055-9965.epi-04-0596
Abstract
This experiment examined the effects of delays in separation and freezing of whole blood components on analytes of interest in studies of prostate cancer prevention, in order to evaluate the feasibility of centralized processing of blood for the multisite Selenium and Vitamin E Cancer Prevention Trial. Blood from 40 healthy men was subjected to four treatment protocols, allowing the contrast of immediate processing to delays of 32, 72, and 144 hours. At 32 hours, simulating refrigerated storage and overnight shipping, there was a 2.9% decrease (95% confidence interval, 0.7-5.1) in insulin-like growth factor-I (IGF-I) but no significant change in carotenoids, tocopherols, testosterone, 3α-androstanediol glucuronide (AAG), sex hormone–binding globulin (SHBG) or insulin-like growth factor binding protein 3 (IGFBP3). A 144-hour processing delay, simulating weekend blood collection or shipping delay, resulted in significant changes in γ-tocopherol (−1.5%), IGF-I (−5.7%), IGFBP3 (−2.9%), SHBG (−4.0%), testosterone (+4.7%), and AAG (+5.5%). The rank-order and intraclass correlations between analytes from blood processed immediately and those subjected to delayed processing were 0.96 or higher for carotenoids, tocopherols, AAG, and SHBG, and between 0.87 and 0.95 for IGF-I, IGFBP3, and testosterone. A 32-hour delay decreased lymphocyte viability from 82.5% to 75.0% (P = 0.45), but a 72-hour delay decreased viability to 36.8% (P < 0.001). Overnight shipping and centralized processing is an acceptable approach to blood collection in large multisite trials examining the cancer-related measures proposed in the Selenium and Vitamin E Cancer Prevention Trial. Longer processing delays, however, have small but statistically significant effects on many analytes and substantially decrease lymphocyte viability.Keywords
This publication has 8 references indexed in Scilit:
- Vitamin C and the Risk of Preeclampsia— Results from Dietary Questionnaire and Plasma AssayEpidemiology, 2002
- SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and designProstate Cancer and Prostatic Diseases, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Principles of Exposure Measurement in EpidemiologyPublished by Oxford University Press (OUP) ,1992
- Sample age and epstein-barr virus transformation of cryopreserved lymphocytesIn Vitro Cellular & Developmental Biology – Animal, 1992
- Effect of transport conditions on the stability of biochemical markers in blood.Clinical Chemistry, 1989
- Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma.Clinical Chemistry, 1988
- Einfluß von Lagerung und Temperatur auf die Analyse von Steroiden in Plasma und Blutcclm, 1984